deoxycytidine has been researched along with Leukemia P388 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, I; Ahmad, MU; Ali, SM; Chen, P; Chien, PY; Khan, AR; Sheikh, S | 1 |
| Amenitsch, H; Bourgaux, C; Couvreur, P; Desmaële, D; Lepêtre-Mouelhi, S; Mangenot, S; Ollivon, M; Pili, B; Poupaert, JH; Reddy, LH | 1 |
| Gilbert, KS; Grindey, GB; Waud, WR; Worzalla, JF | 1 |
| Ahluwalia, GS; Barchi, JJ; Cooney, DA; Covey, JM; Gharehbaghi, K; Hochman, I; Jayaram, HN; Paull, KD | 1 |
| Kawaguchi, T; Saneyoshi, M; Shudo, K; Tomikawa, A; Yamaguchi, T | 1 |
| Marańda, E; Robak, T | 1 |
| Matsuda, A; Ogawa, A; Sasaki, T; Tanaka, M | 1 |
| Marañda, E; Robak, T; Szmigielska, A | 1 |
| Hanaoka, K; Hisaoka, M; Ikeda, T; Iwabuchi, H; Kaneko, M; Kobayashi, T; Kurakata, S; Matsuda, A; Mitsuhashi, Y; Miura, S; Nakagawa, A; Nomura, T; Sasaki, T; Shibayama, T; Suzuki, M; Tanaka, K; Tanzawa, F; Tomida, A; Tsuruo, T; Wataya, Y | 1 |
| Birnbaum, GI; Cheng, YC; Clarke-Katzenburg, RH; Gabe, EJ; Giziewicz, J; Lin, TS; Liu, MC; Luo, MZ; Mancini, WR; Prusoff, WH | 1 |
| Arita, M; Fujii, A; Matsuda, A; Okumoto, T; Sakata, S; Sasaki, T; Ueda, T; Yamagami, K | 1 |
| Boder, GB; Grindey, GB; Hertel, LW; Kroin, JS; Poore, GA; Rinzel, SM; Todd, GC | 1 |
| Ahluwalia, GS; Arnold, ST; Balzarini, J; Cohen, MB; Cooney, DA; Dalal, M; Johns, DG; Kang, GJ; McMahon, JB; Wilson, YA | 1 |
| Balzarini, J; Broder, S; Cooney, DA; Dalal, M; Johns, DG; McMahon, JB; Mitsuya, H; Nadkarni, M | 1 |
14 other study(ies) available for deoxycytidine and Leukemia P388
| Article | Year |
|---|---|
In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.
Topics: Animals; Antineoplastic Agents; Body Weight; Cardiolipins; Cell Proliferation; Deoxycytidine; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; HT29 Cells; Humans; Leukemia P388; Leukocyte Count; Mice; Mice, SCID; Neutropenia; Nucleoside Transport Proteins; Pancreatic Neoplasms; Thioinosine; Xenograft Model Antitumor Assays | 2006 |
Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.
Topics: Animals; Antineoplastic Agents; Cryoelectron Microscopy; Deoxycytidine; Gemcitabine; Leukemia P388; Macromolecular Substances; Mice; Mice, Inbred DBA; Models, Molecular; Nanostructures; Nanotechnology; Scattering, Small Angle; Squalene; X-Ray Diffraction | 2008 |
Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gemcitabine; Leukemia P388; Mice; Molecular Structure | 1996 |
Studies on the mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) in mammalian lymphoblasts.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Survival; Deoxycytidine; DNA, Neoplasm; Humans; Leukemia P388; Lymphocytes; Mice; Mice, Inbred Strains; Phosphorylation; Tumor Cells, Cultured | 1996 |
Chiral influences of feedback inhibition with dCTP on murine deoxycytidine kinase.
Topics: Adenosine Triphosphate; Animals; Deoxycytidine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; Feedback; Humans; Kinetics; Leukemia P388; Mice; Stereoisomerism; Substrate Specificity; Zalcitabine | 1997 |
Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Interactions; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice; Tumor Necrosis Factor-alpha | 1998 |
Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
Topics: Animals; Antimetabolites, Antineoplastic; Cytidine; Deoxycytidine; DNA, Neoplasm; Drug Screening Assays, Antitumor; Female; Fibrosarcoma; Humans; Inhibitory Concentration 50; Leukemia P388; Neoplasm Transplantation; RNA, Neoplasm; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice | 1999 |
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformation; Breast Neoplasms; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Deoxycytidine Kinase; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; KB Cells; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Mitomycin; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Nude; Specific Pathogen-Free Organisms; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine | 1999 |
Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Crystallization; Cytarabine; Deoxycytidine; Female; Humans; Leukemia L1210; Leukemia P388; Leukemia, Lymphoid; Mice; Molecular Structure; Nucleosides; Sarcoma 180; Simplexvirus; Tumor Cells, Cultured; X-Ray Diffraction | 1991 |
Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
Topics: Animals; Cytarabine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Tumor Cells, Cultured | 1991 |
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Deoxycytidine; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Gemcitabine; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Neoplasms, Experimental; Tumor Cells, Cultured | 1990 |
Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
Topics: Animals; Azacitidine; Biological Transport; Colonic Neoplasms; Cytidine; Deoxycytidine; Deoxycytidine Kinase; DNA; Drug Resistance; Humans; Leukemia P388; Mice; Phosphorylation | 1986 |
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.
Topics: Animals; Cell Line; Chromatography, High Pressure Liquid; Cytopathogenic Effect, Viral; Deltaretrovirus; Deoxycytidine; Deoxycytidine Kinase; Female; Goats; Humans; Leukemia P388; Mice; Structure-Activity Relationship; Thioinosine; Zalcitabine | 1986 |